ADVENTRX Pharmaceuticals Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 0.5 | 0.0 | 0.5 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 25.7 | 29.9 | 13.7 |
| Depreciation & Amortization | (0.8) | (0.1) | 0.0 |
| Operating Income | (24.3) | (29.8) | (13.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 2.2 | 0.5 | (11.6) |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (22.1) | (29.3) | (24.8) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (22.1) | (29.3) | (24.8) |
| Continuing Operations | (22.1) | (29.3) | (24.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (22.1) | (29.3) | (24.8) |
| Total Net Income | (22.1) | (29.3) | (24.8) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.25) | (0.40) | (0.41) |
| Dividends per Share | -- | -- | -- |






